文献速递前列腺癌

磁共振靶向穿刺在前列腺癌导管内癌和筛状癌检出中的作用

Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma.
PubMed 文献 · J Urol · 2018-02-02

该研究纳入154例接受多参数磁共振/超声融合靶向穿刺及系统六针穿刺的患者,比较两种方法对导管内/筛状模式前列腺癌的检出率。靶向穿刺检出93例前列腺癌,系统穿刺检出76例(p=0.008);导管内/筛状阳性肿瘤23例中,靶向穿刺检出22例,系统穿刺检出3例(p<0.001)。结论认为靶向穿刺显著提高导管内/筛状阳性前列腺癌的检出。

要点

  • 多参数磁共振/超声融合靶向穿刺较磁共振阴性区域系统六针穿刺显著提高前列腺癌检出率(p=0.008)。
  • 导管内/筛状阳性肿瘤在靶向穿刺部位检出22例,在系统穿刺部位仅检出3例(p<0.001)。
  • 导管内/筛状模式与PI-RADS评分5分及较低的表观扩散系数值显著相关(p=0.008和0.005)。

核心结论

  • 多参数磁共振/超声融合靶向穿刺与磁共振阴性区域系统六针穿刺相比,显著增加导管内/筛状阳性前列腺癌的检出。
  • 该结果支持磁共振在提高临床侵袭性导管内/筛状阳性前列腺癌检出中的作用。

研究设计与样本

  • 单中心前瞻性维护数据库回顾性分析,纳入2013年1月至2016年5月接受多参数磁共振/超声融合靶向穿刺及同步磁共振阴性区域系统六针穿刺的患者。
  • 共纳入154例患者,其中51例两种穿刺均阴性,103例用于磁共振与导管内/筛状模式的相关性分析。
  • 由2名读者回顾性评估PI-RADS v2评分、最大径、表观扩散系数及动态对比增强序列阳性/阴性;由2名泌尿病理学家评估Gleason评分/分级分组及导管内/筛状模式存在与否。

主要发现

  • 靶向穿刺检出前列腺癌93例,磁共振阴性区域系统六针穿刺检出76例(p=0.008)。
  • 导管内/筛状阳性肿瘤检出23例,其中靶向穿刺部位22例,系统穿刺部位3例(p<0.001)。
  • 导管内/筛状模式与PI-RADS评分5分显著相关(p=0.008),与表观扩散系数值降低显著相关(p=0.005)。
  • 23例导管内/筛状模式病例中,既往12针标准系统穿刺阴性8例,分级分组1级11例。

临床怎么用

  • 对于多参数磁共振阳性区域,靶向穿刺应作为检出导管内/筛状阳性前列腺癌的重要手段。
  • 磁共振阴性区域系统六针穿刺对导管内/筛状阳性肿瘤的检出贡献较低。

局限性

  • 单中心回顾性研究,样本量有限(154例),结论需外推验证。
  • 仅纳入磁共振阴性区域系统六针穿刺,未与其他系统穿刺方案比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of this study was to compare biopsy detection of intraductal and cribriform pattern invasive prostate carcinoma in multiparametric magnetic resonance imaging positive and negative regions of the prostate. MATERIALS AND METHODS: We queried a prospectively maintained, single institution database to identify patients who underwent multiparametric magnetic resonance imaging/ultrasound fusion targeted biopsy and concurrent systematic sextant biopsy of magnetic resonance imaging negative regions between January 2013 and May 2016. All multiparametric magnetic resonance imaging targets were reviewed retrospectively by 2 readers for the PI-RADS™ (Prostate Imaging-Reporting and Data System), version 2 score, the maximum dimension, the apparent diffusion coefficient parameter and whether positive or negative on dynamic contrast enhancement sequence. Biopsy slides were reviewed by 2 urological pathologists for Gleason score/Grade Group and the presence or absence of an intraductal/cribriform pattern. RESULTS: A total of 154 patients were included in study. Multiparametric magnetic resonance imaging/ultrasound fusion targeted biopsy and systematic sextant biopsy of magnetic resonance imaging negative regions were negative for prostate carcinoma in 51 patients, leaving 103 available for the correlation of multiparametric magnetic resonance imaging and the intraductal/cribriform pattern. Prostate carcinoma was identified by multiparametric magnetic resonance imaging/ultrasound fusion targeted biopsy in 93 cases and by systematic sextant biopsy of magnetic resonance imaging negative regions in 76 (p = 0.008). Intraductal/cribriform positive tumor was detected in 23 cases, including at the multiparametric magnetic resonance imaging/ultrasound fusion targeted biopsy site in 22 and at the systematic sextant biopsy of magnetic resonance imaging negative region site in 3 (p <0.001). The intraductal/cribriform pattern was significantly associated with a PI-RADS score of 5 and a decreasing apparent diffusion coefficient value (p = 0.008 and 0.005, respectively). In 19 of the 23 cases with the intraductal/cribriform pattern prior 12-core standard systematic biopsy was negative in 8 and showed Grade Group 1 disease in 11. CONCLUSIONS: Multiparametric magnetic resonance imaging/ultrasound fusion targeted biopsy was associated with significantly increased detection of intraductal/cribriform positive prostate carcinoma compared to systematic sextant biopsy of multiparametric magnetic resonance imaging negative regions. This supports the role of magnetic resonance imaging to enhance the detection of clinically aggressive intraductal/cribriform positive prostate carcinoma.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Prendeville S, Gertner M, Maganti M, et al. Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma. J Urol. 2018. PMID: 29408568. doi:10.1016/j.juro.2018.01.081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。